SecSonar.com

Pro-Dex, Inc. (PDEX)

Pro-Dex, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Pro-Dex, Inc. (PDEX) is a Medical - Instruments & Supplies company based in US with a market capitalization of $214.6M. Revenue grew 23.7% year-over-year and free cash flow was negative at -$2.9M. This page tracks PDEX's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 146 employees · IPO Aug 7, 1986

Valuation

Valuation & price

$59.27 · as of May 17, 2026 · -12.2% vs 52w high

22.2

P/E ratio

Latest-FY diluted EPS

5.86

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$67.50$45.70$23.91Jul 25Dec 25Jul 26Jul 7, 25$46.22Jul 9, 25$48.99Jul 11, 25$45.01Jul 15, 25$45.18Jul 17, 25$47.27Jul 21, 25$46.66Jul 23, 25$50.60Jul 25, 25$49.43Jul 29, 25$51.52Jul 31, 25$50.05Aug 4, 25$45.71Aug 6, 25$45.73Aug 11, 25$38.41Aug 13, 25$42.34Aug 15, 25$42.73Aug 19, 25$43.92Aug 21, 25$48.00Aug 25, 25$46.21Aug 27, 25$45.50Aug 29, 25$46.88Sep 3, 25$46.47Sep 5, 25$38.19Sep 9, 25$36.39Sep 11, 25$35.19Sep 16, 25$33.81Sep 18, 25$34.76Sep 22, 25$34.34Sep 24, 25$34.94Sep 26, 25$33.99Sep 30, 25$33.85Oct 2, 25$33.59Oct 6, 25$33.84Oct 8, 25$34.74Oct 10, 25$33.33Oct 14, 25$25.35Oct 16, 25$23.91Oct 21, 25$26.08Oct 23, 25$28.07Oct 27, 25$28.87Oct 29, 25$30.71Oct 31, 25$36.24Nov 4, 25$33.74Nov 6, 25$32.59Nov 10, 25$32.53Nov 12, 25$32.48Nov 14, 25$32.09Nov 18, 25$30.34Nov 20, 25$30.83Nov 25, 25$36.41Nov 28, 25$36.44Dec 2, 25$37.56Dec 4, 25$40.70Dec 8, 25$41.00Dec 10, 25$42.49Dec 12, 25$43.38Dec 16, 25$44.70Dec 18, 25$42.18Dec 22, 25$42.68Dec 24, 25$40.40Dec 29, 25$39.44Jan 2, 26$37.72Jan 6, 26$40.96Jan 8, 26$41.30Jan 12, 26$43.27Jan 14, 26$41.08Jan 16, 26$42.23Jan 21, 26$40.85Jan 23, 26$39.12Jan 27, 26$41.23Jan 29, 26$39.41Feb 2, 26$40.06Feb 4, 26$39.30Feb 9, 26$39.70Feb 11, 26$38.03Feb 13, 26$39.48Feb 18, 26$40.66Feb 20, 26$39.52Feb 24, 26$41.95Feb 26, 26$44.68Mar 2, 26$46.13Mar 4, 26$48.05Mar 6, 26$45.29Mar 10, 26$44.72Mar 12, 26$46.82Mar 17, 26$50.00Mar 19, 26$49.00Mar 23, 26$47.95Mar 25, 26$48.61Mar 27, 26$48.98Mar 31, 26$49.12Apr 2, 26$51.67Apr 7, 26$49.78Apr 9, 26$50.87Apr 13, 26$52.40Apr 15, 26$51.26Apr 17, 26$53.40Apr 22, 26$50.76Apr 24, 26$52.10Apr 28, 26$51.51Apr 30, 26$50.14May 4, 26$51.23May 6, 26$58.50May 8, 26$59.27May 12, 26$56.50May 14, 26$58.65May 18, 26$59.16May 20, 26$63.47May 22, 26$63.52May 28, 26$67.50Jun 1, 26$66.93Jun 3, 26$65.17Jun 5, 26$65.21Jun 9, 26$65.00Jun 11, 26$62.92Jun 15, 26$63.72Jun 17, 26$60.46Jun 22, 26$64.40Jun 24, 26$64.72Jun 26, 26$61.47Jul 2, 26$61.33
$23.9152-week range$67.50
Loading valuation history…

Fundamentals

Key fundamentals

$214.6M

Market cap

23.7%

Revenue growth (YoY)

29.3%

Gross margin

-$2.9M

Free cash flow (USD)

$9.4M

Net debt

-6.0%

Share dilution

2/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$20.2MFY 2017$21.9MFY 2018$22.5MFY 2019$27.2MFY 2020$34.8MFY 2021$42.0MFY 2022$42.0MFY 2023$46.1MFY 2024$53.8MFY 2025$66.6M
$20.2M$66.6M

Free cash flow by year

2016 → 2025

FY 2016$131.0KFY 2017$2.6MFY 2018$2.2MFY 2019$1.9MFY 2020$5.3MFY 2021$-2.5MFY 2022$-2.5MFY 2023$4.5MFY 2024$5.2MFY 2025$-2.9M
$131K-$2.9M

Gross margin by year

2021 → 2025

FY 202131.2%FY 202231.2%FY 202327.7%FY 202427.0%FY 202529.3%
31.2%29.3%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

1

Insider sells · 90 days

Earnings

Last report: 10-Q filed Apr 30, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventInvestor Presentation InitiatedJun 17, 2026Filing
  • Insider sellInsider Sell $626K · 10b5-1 PlanVan Kirk Richard Lee Jr · Director, Chief Executive Officer · $626.2KMay 26, 2026Filing
  • Quarterly report10-Q FiledApr 30, 2026Filing
  • 8-K eventEarnings ReleaseApr 30, 2026Filing

Questions

Frequently asked questions

What is Pro-Dex, Inc.'s market cap?

Pro-Dex, Inc. (PDEX) has a market capitalization of $214.6M.

What is PDEX's P/E ratio?

PDEX trades at a price-to-earnings ratio of 22.2, based on its latest fiscal-year diluted earnings per share and the most recent cached price.

What is PDEX's price-to-book (P/B) ratio?

PDEX trades at 5.86 times book value per share.

Are insiders buying PDEX stock?

SEC Form 4 filings show no open-market insider buys at Pro-Dex, Inc. in the last 90 days (1 sell).

Same arena

Related companies in Medical - Instruments & Supplies

UTMD

Utah Medical Products, Inc.

$213.6M

SMTI

Sanara MedTech Inc.

$213.1M

STXS

Stereotaxis, Inc.

$196M

INFU

InfuSystem Holdings, Inc.

$190.7M

KRMD

KORU Medical Systems, Inc.

$188.8M

OSUR

OraSure Technologies, Inc.

$294.9M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.